0KW4.L
ResMed Inc
Q2 2025 Report
ResMed Inc (0KW4.L) QQ2 2025 Financial Results: Promising Growth and Strengthened Market Position...
Read full report
Executive Summary
In Q3 2025, ResMed Inc demonstrated strong financial performance, with revenues reaching $1.29 billion, marking a 7.92% year-over-year increase. The company recorded a net income of $365 million, contributing to an impressive 21.48% increase in net income on a year-over-year basis and a more modest 5.93% on a quarter-over-quarter basis. Management attributed this success to increased demand for respiratory care and cloud-based solutions, enhancing patient engagement and operational efficiencies. The earnings per share (EPS) saw a notable rise of 22.06% year-over-year, further reflecting the company's effective cost management and improved operational performance. These results highlight ResMed's robust market position and ability to capitalize on growth opportunities in the healthcare industry.
Key Performance Indicators
Revenue
1.29B
QoQ: 0.75% | YoY:7.92%
Gross Profit
766.41M
59.33% margin
QoQ: 2.01% | YoY:12.45%
Operating Income
426.27M
QoQ: 2.16% | YoY:13.80%
Net Income
365.04M
QoQ: 5.93% | YoY:21.48%
EPS
2.49
QoQ: 2.47% | YoY:22.06%
Revenue Trend
Margin Analysis
Key Insights
- **Revenue**: $1,291,736,000 (YoY growth: 7.92%, QoQ growth: 0.75%)
- **Gross Profit**: $766,408,000 (YoY growth: 12.45%, QoQ growth: 2.01%)
- **Operating Income**: $426,268,000 (YoY growth: 13.80%, QoQ growth: 2.16%)
- **Net Income**: $365,041,000 (YoY growth: 21.48%, QoQ growth: 5.93%)
- **EPS**: $2.49 (YoY growth: 22.06%, QoQ growth: 2.47%)